Ausgabe 5/2006
Inhalt (19 Artikel)
18F-DOPA PET/CT and neuroendocrine tumours
Cristina Nanni, Domenico Rubello, Stefano Fanti
Developing nuclear medicine in developing countries: IAEA’s possible mission
Maurizio Dondi, Pedro Andreo
Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas
Norbert Galldiks, Lutz W. Kracht, Lothar Burghaus, Anne Thomas, Andreas H. Jacobs, Wolf–Dieter Heiss, Karl Herholz
Role of 18F-FDG PET/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results
Cristina Nanni, Elena Zamagni, Mohsen Farsad, Paolo Castellucci, Patrizia Tosi, Delia Cangini, Eugenio Salizzoni, Romeo Canini, Michele Cavo, Stefano Fanti
Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours
Margarida Rodrigues, Tatjana Traub-Weidinger, Shuren Li, Bettina Ibi, Irene Virgolini
The presentation of malignant tumours and pre-malignant lesions incidentally found on PET-CT
Einat Even-Sapir, Hedva Lerman, Mordechai Gutman, Gennady Lievshitz, Limor Zuriel, Aaron Polliack, Moshe Inbar, Ur Metser
Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis
P. Mahy, M. De Bast, J. Gillart, D. Labar, V. Grégoire
In vitro validation of bioluminescent monitoring of disease progression and therapeutic response in leukaemia model animals
Yusuke Inoue, Arinobu Tojo, Rieko Sekine, Yasushi Soda, Seiichiro Kobayashi, Akiko Nomura, Kiyoko Izawa, Toshio Kitamura, Toshiyuki Okubo, Kuni Ohtomo
99mTc-HYNIC-annexin V SPECT imaging of acute stroke and its response to neuroprotective therapy with anti-Fas ligand antibody
Francis G. Blankenberg, Judy Kalinyak, Liping Liu, Maya Koike, Danye Cheng, Michael L. Goris, Allan Green, Jean-Luc Vanderheyden, David C. Tong, Midori Anne Yenari
Fully automatic diagnostic system for early- and late-onset mild Alzheimer’s disease using FDG PET and 3D-SSP
Kazunari Ishii, Atsushi K. Kono, Hiroki Sasaki, Naokazu Miyamoto, Tetsuya Fukuda, Setsu Sakamoto, Etsuro Mori
Respiratory gating of cardiac PET data in list-mode acquisition
Lefteris Livieratos, Kim Rajappan, Lars Stegger, Klaus Schafers, Dale L. Bailey, Paolo G. Camici
18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries
Kumiko Okane, Masanobu Ibaraki, Hideto Toyoshima, Shigeki Sugawara, Kazuhiro Takahashi, Shuichi Miura, Eku Shimosegawa, Junichiro Satomi, Keishi Kitamura, Tomohiko Satoh
First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent
Yicheng Ni, Dieter Huyghe, Kristin Verbeke, Peter A. de Witte, Johan Nuyts, Luc Mortelmans, Feng Chen, Guy Marchal, Alfons M. Verbruggen, Guy M. Bormans
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution
Sandrine Ballot, Nicolas Noiret, François Hindré, Benoît Denizot, Etienne Garin, Holisoa Rajerison, Jean-Pierre Benoit
Dose selection for radioiodine therapy of borderline hyperthyroid patients according to thyroid uptake of 99mTc-pertechnetate: applicability to unifocal thyroid autonomy?
Michael J. Reinhardt, Kim Biermann, Michael Wissmeyer, Freimut D. Juengling, Holger Brockmann, Dirk von Mallek, Samer Ezziddin, Alexius Y. Joe, Thomas M. Krause
Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine
Florence Perillo-Adamer, Angelika Bischof Delaloye, Céline S. Genton, Andreas O. Schaffland, Yves M. Dupertuis, Franz Buchegger
Imaging of primary breast cancer with 18F-fluorodeoxythymidine PET-CT reveals heterogeneity of proliferation throughout the tumour
Mark Beresford, Bal Sanghera, Wai-Lup Wong, Andreas Makris
Scintigraphic appearance of “linitis plastica” in a patient with gastric non-Hodgkin’s lymphoma on 18F-FDG imaging
İlknur Ak, Burcu Aydemir, Zafer Gülbaş